<DOC>
	<DOCNO>NCT00604344</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial investigate efficacy insulin detemir blood glucose control subject insulin require diabetes .</brief_summary>
	<brief_title>Efficacy Safety Insulin Detemir Subjects With Insulin Requiring Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Duration diabetes mellitus least 2 year Current treatment basalbolus regimen least 12 week use intermediate/longacting human insulin insulin aspart HbA1C 11.0 % Impaired renal function Impaired hepatic function Serious heart diseases Known hypoglycaemia unawareness recurrent major hypoglycaemia Proliferative retinopathy maculopathy require acute treatment Uncontrolled treated/untreated hypertension Current treatment total insulin dose 100 IU/day Current treatment expect screening start treatment systemic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>